These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28367707)

  • 21. Depressive breakthrough.
    Nierenberg AA; Alpert JE
    Psychiatr Clin North Am; 2000 Dec; 23(4):731-42. PubMed ID: 11147244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier?
    Faedda GL; Marangoni C
    CNS Spectr; 2017 Apr; 22(2):120-125. PubMed ID: 27831463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.
    Dodd S; Mitchell PB; Bauer M; Yatham L; Young AH; Kennedy SH; Williams L; Suppes T; Lopez Jaramillo C; Trivedi MH; Fava M; Rush AJ; McIntyre RS; Thase ME; Lam RW; Severus E; Kasper S; Berk M
    World J Biol Psychiatry; 2018 Aug; 19(5):330-348. PubMed ID: 28984491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of antidepressants to treat depression in bipolar disorder.
    El-Mallakh RS; Karippot A
    Psychiatr Serv; 2002 May; 53(5):580-4. PubMed ID: 11986507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?
    Berk M; Dodd S
    Med Hypotheses; 2005; 65(1):39-43. PubMed ID: 15893115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major depressive disorder treatment guidelines in America and Europe.
    Davidson JR
    J Clin Psychiatry; 2010; 71 Suppl E1():e04. PubMed ID: 20371031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are antidepressants equally effective in the long-term treatment of major depressive disorder?
    Buoli M; Cumerlato Melter C; Caldiroli A; Altamura AC
    Hum Psychopharmacol; 2015 Jan; 30(1):21-7. PubMed ID: 25393889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary.
    Malhi GS; Bell E; Singh AB; Bassett D; Berk M; Boyce P; Bryant R; Gitlin M; Hamilton A; Hazell P; Hopwood M; Lyndon B; McIntyre RS; Morris G; Mulder R; Porter R; Yatham LN; Young A; Murray G
    Bipolar Disord; 2020 Dec; 22(8):788-804. PubMed ID: 33320412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder.
    Carrasco JL; Kornstein SG; McIntyre RS; Fayyad R; Prieto R; Salas M; Mackell J; Boucher M
    Int Clin Psychopharmacol; 2016 May; 31(3):134-46. PubMed ID: 26895080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major depressive disorder treatment guidelines in China.
    Zhang M
    J Clin Psychiatry; 2010; 71 Suppl E1():e06. PubMed ID: 20371033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder.
    Nierenberg AA; Ostacher MJ; Huffman JC; Ametrano RM; Fava M; Perlis RH
    J Occup Environ Med; 2008 Apr; 50(4):428-36. PubMed ID: 18404015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach.
    Fava GA; Ruini C; Sonino N
    CNS Drugs; 2003; 17(15):1109-17. PubMed ID: 14661988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder.
    Patkar AA; Pae CU
    CNS Drugs; 2013 May; 27 Suppl 1():S29-37. PubMed ID: 23709359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of pharmacotherapy of major depression in children and adolescents.
    Ambrosini PJ
    Psychiatr Serv; 2000 May; 51(5):627-33. PubMed ID: 10783181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A primary care focus on the diagnosis and treatment of major depressive disorder in adults.
    Halaris A
    J Psychiatr Pract; 2011 Sep; 17(5):340-50. PubMed ID: 21926529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment adherence in the recurrent depressive disorders].
    Spadone C
    Encephale; 2002; 28(3 Pt 1):255-9. PubMed ID: 12091787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.